Jianghong Rao

This inventor holds 21 USPTO granted patents and 13 published patent applications and 1 EPO patent, primarily in Molecular Probes. Top assignees: Leland Stanford Junior University, Texas A&M University System, University of California. Active years: 2008-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianghong Rao. Retrieved from https://idiyas.com/inventor/jianghong-rao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 13)

% Patents Active = 42.9

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 69(Granted Patents)

Location History:

La Jolla, CA (US) (2008)
Sunnyvalle, CA (US) (2013)
Stanford, CA (US) (2019)
Sunnyvale, CA (US) (2011 - 2020)
Palo Alto, CA (US) (2008 - 2023)

Company Filing History:

17 out of 5,512

Leland Stanford Junior University

patents

5 out of 1,328

Texas A&M University System

patents

2 out of 16,025

University of California

where one patent can have more than one assignee

Years Active: 2008-2023

Loading Chart...

Areas of Expertise:

Molecular Probes

Caspase-3

Beta-Lactamase

Mycobacteria

Theranostics

Nanoprobes

Imaging Techniques

Fluorogenic Substrates

Reactive Oxygen Species

In Vivo Diagnostics

Quantum Dot

Bioluminogenic Assays

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11679168 - Caspase-3-triggered molecular self-assembling PET probes and uses thereof (2023-06-20),

2. 10570150 - 6,7-trans cephalosporin-based probes for detecting bacteria expressing a metallo-beta-lactamase (2020-02-25),

3. 10370538 - Probes for rapid and specific detection of mycobacteria (2019-08-06),

4. 10344165 - 2,7-disubstituted cephalosporin derivatives as β-lactamase substrates and methods for their use for the diagnosis of tuberculosis (2019-07-09),

5. 10201622 - Tumour-targeted theranostic (2019-02-12),

6. 10196412 - Probe for imaging PARP-1 activity (2019-02-05),

7. 9849198 - Discrete imaging of hepatic oxidative and nitrosative stress with two-channel nanoparticles for in vivo drug safety screening (2017-12-26),

8. 9834681 - 2,7-disubstituted cephalosporin derivatives as beta-lactamase substrates and methods for their use for the diagnosis of tuberculosis (2017-12-05),

9. 9677112 - β-lactamase substrates and methods of their use for the diagnosis of tuberculosis (2017-06-13),

10. 9675713 - Nanoprobes for sensing of reactive oxygen and reactive nitrogen species (2017-06-13),

11. 9642922 - Caspase-triggered nano-aggregation probes and methods of use (2017-05-09),

12. 9441261 - Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics (2016-09-13),

13. 9138490 - Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics (2015-09-22),

14. 8592227 - Hybrid quantum dot/protein nanostructure, methods of making, and methods of use thereof (2013-11-26),

15. 8530178 - Hydrolase detection system with caged substrates (2013-09-10),

Title: Inventor Jianghong Rao: Pioneering Innovations in Sunnyvale

Introduction: Jianghong Rao is a distinguished inventor based in Sunnyvale, California, known for her groundbreaking contributions to the field of biotechnology and medical diagnostics.

Latest Patents: Jianghong Rao holds several patents related to novel diagnostic tools and imaging technologies that have revolutionized the way diseases are detected and monitored.

Career Highlights: With a background in bioengineering and molecular imaging, Jianghong Rao has had a successful career working at renowned research institutions and leading biotech companies, where she has spearheaded numerous projects that have led to significant advancements in the healthcare industry.

Collaborations: Throughout her career, Jianghong Rao has collaborated with top scientists, researchers, and medical professionals to develop cutting-edge solutions for early disease detection and personalized medicine, cementing her reputation as a visionary in the field.

Conclusion: Jianghong Rao's relentless pursuit of innovation and her commitment to improving healthcare through technology make her a trailblazer in the field of biotechnology, with a lasting impact on the future of medical diagnostics.

Profile summary based on public USPTO records.